|

Yttrium-90 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Y-90

Pipeline

Phase 1: 1

Top Sponsors

  • University of Michigan Rogel Cancer Center1

Indications

  • Liver Malignancy1
  • Liver Cancer1
  • Cancer1

Ann Arbor, Michigan1 trial

Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.

University of Michigan Rogel Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.